logo-loader

NA Proactive news snapshot: Medexus Pharmaceuticals, Pressure BioSciences, Next Green Wave, Ventura Cannabis, Biocept UPDATE ...

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Seelos Therapeutics - NA Proactive news snapshot: Seelos Therapeutics, Allot, Japan Gold, Weekend Unlimited …
Your daily round-up from the world of Proactive

Medexus Pharmaceuticals Inc (CVE:KMDP) (OTCMKTS:PDDPF) posted fiscal first-quarter results after the bell on Thursday showing a healthy year-over-year increase in revenue and positive underlying earnings. The Montreal-based drugmaker saw its revenue in the quarter to end June 2019 jump to C$16.1 million, up from C$3.2 million in the same quarter in the prior-year.  The company also finished the quarter with cash and cash equivalents of C$27.4 million, according to its statement.

Pressure BioSciences Inc (OTCMKTS:PBIO) announced Thursday that it has won two more customers for its water-soluble CBD manufacturing system, the BaroShear K45. In July, Pressure Bio announced the sale of its first BaroShear K45 system to Nano CBD Cosmetics LLC. The two new orders are from Vancouver-based NanoPeak Solutions Inc and a privately-owned company in Las Vegas, Nevada.

Next Green Wave Holdings Inc (CSE:NGW) (OTCMKTS:NXGWF) hit a new milestone this week with the successful completion of its first cannabis harvest. The Vancouver-based company said Thursday that all 14 flower rooms at the company’s California facility are stocked with plants, and six of them are in the flowering stage. The cannabis company told investors that it expects to become fully operational this month.

Ventura Cannabis and Wellness Corp (CSE:VCAN) has received the stamp of approval from regulators to close its acquisition of Kush Rush, a California dispensary and delivery service. Los Angeles-based Ventura said Thursday that the Bureau of Cannabis Control approved the acquisition, part of Ventura’s strategy to build a network of California dispensaries. Kush Rush will serve as a template for Ventura’s California dispensaries under contract or application, the company said in a statement.

Biocept Inc (NASDAQ:BIOC) announced Thursday it will tout its patented liquid biopsy technology, Target Selector, at a major lung cancer conference in Spain next month.  The San Diego’s company’s Target Selector detects and isolates cancer biomarkers such as circulating tumor cells (CTCs) and cell-free circulating tumor DNA (ctDNA). Biocept offers the tests commercially to doctors, hospitals, clinics and researchers, with a focus on lung, breast, gastric, colorectal and prostate cancers as well as melanoma.

Seelos Therapeutics Inc. (NASDAQ:SEEL) revealed Thursday that the US Food and Drug Administration (FDA) has accepted the Investigation New Drug (IND) application for its SLS-005 (trehalose) treatment and has advised that the company may proceed with the proposed clinical trial on patients with Sanfilippo syndrome. The clinical-stage biopharmaceutical company said the clinical trial for SLS-005-201 is a combined Phase IIb/III, multicenter study designed to assess safety, tolerability and efficacy of trehalose IV in Sanfilippo A and B based on functional outcomes, biomarkers, neuro-cognitive assessments and quality of life measurements.

Allot Ltd (NASDAQ:ALLT) (TASE:ALLT), the security and smart network intelligence solutions company, said that Hutchison Drei Austria has launched “lnternetschutz” — a security-as-a-service powered by Allot's NetworkSecure solution to protect its mobile phone and home users against cyber threats. In a statement, the company said the deal between Drei and Allot is based on a recurring monthly fee derived from the actual number of subscribers using Allot’s cyber security solution. Drei, enabled by Allot’s NetworkSecure, will offer its customers a service to protect themselves against malware, phishing, ransomware, and crypto mining.

Japan Gold Corp (CVE:JG) has raised C$7.14 million through an oversubscribed private placing to advance exploration in the Asian country, it revealed on Thursday. Investor demand saw the firm increase the financing from the C$5 million initially sought.

Weekend Unlimited Inc (CSE:POT) (OTCMKTS:WKULF), the lifestyle-focused cannabis company, said it has launched its flagship wknd! branded products in Washington State. The Vancouver-based company has developed products for the wknd! brand which include cannabis-filled cigars, pre-rolls and vape cartridges. In a statement, Weekend Unlimited CEO Chris Backus described the launch as a “significant milestone” for the company. “As of this week, wknd! branded products are in full sales launch in Washington state. Inventory is fully stocked, sales teams have entered retail stores with product sample packs, and purchase orders are being taken,” said Backus.

Ceylon Graphite Corp (CVE:CYL) (OTCMKTS:CYLYF) told investors on Thursday that new assay results from the company’s Sri Lankan projects revealed extremely high purity levels. The samples taken from the M1 site in the Malsiripura area in Sri Lanka indicated a carbon content of 99.2%, which Ceylon said is “vastly superior” to other natural graphite sources. Graphite mined in Sri Lanka is known to be some of the purest in the world, and currently accounts for less than 1% of the world graphite production.

Dunnedin Ventures Inc (CVE:DVI) has welcomed first exploration results from its MPD copper-gold porphyry project in British Columbia, which show the potential for a large mineral system. The firm carried out mapping, prospecting, sampling and resampling of historic trenches with initial work consisting of 93 rock chip samples covering 127 metres of aggregate strike length in the so-called 'Man' area of the property.

One World Lithium Inc (CSE:OWLI) (OCTMKTS :OWRDF) announced Thursday that it has appointed Montgomery and Associates as the operator for its upcoming drill programs at the Salar del Diablo lithium brine project in Mexico. Vancouver-based OWL told investors that Montgomery and Associates is planning to diamond drill four holes of approximately 600 meters depth to collect around 20 groundwater samples from each hole

Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP) said Thursday that it had launched ChrgD+, a water-soluble hemp oil, in a powdered format with the help of its drug delivery system DehydraTECH, which works by helping the body absorb compounds faster and more effectively. In a statement, the Kelowna, British Columbia-based biotechnology company said the product was available for sale online in the US through chrgd.life

New Pacific Metals Corp. (CVE:NUAG) (OTCMKTS:NUPMF) announced that its CEO, Dr. Rui Feng, has donated 200,000 shares of the company to BC Parks Foundation, a registered non-profit organization. The Foundation’s mission is to enhance and pass on the legacy of British Columbia’s world class parks by catalyzing support and resources so that they flourish forever.  The Foundation’s primary role is to promote and support public interest, engagement and involvement in parks and encourage others to contribute.  The company said the Dr. Feng’s donation will help the Foundation to enhance and protect British Columbia’s parks, wildlife, habitat, and ecosystems from pollution and climate change.

Codebase Ventures Inc (CSE:CODE) (OTCMKTS:BKLLF) announced Thursday the appointment of Zach Stadnyk as president and CEO of its subsidiary, Code Cannabis Investments. Stadnyk is a corporate finance and advisory professional with extensive experience in the expanding cannabis industry, the company said in a statement. He has held management positions in corporate finance at Supreme Cannabis Company Inc (CSE:FIRE) (OTCMKTS:SPRWF) and investor relations and corporate finance at FSD Pharma Inc (CSE:HUGE) (OTCMKT:FSDDF). He has also served on the advisory board for 1933 Industries Inc (CSE:TGIF) (OTCMKTS).

Exactus Inc (OTCMKTS:EXDI), the CBD producer, announced late Wednesday that Emiliano Aloi, the company’s president, will assume the duties of interim CEO and said it has launched a search for a new CEO following the departure of Philip Young. In a statement, Exactus noted that Aloi has over 15 years of agroindustrial experience with five years of CBD-related experience, including seed selection, cultivation, harvesting and manufacturing.

Blackrock Gold Corporation (CVE:BRC) (OTCMKTS:BKRRF) told investors Thursday that it had received C$205,500 from the exercise of previously issued warrants and options. In a brief statement, the company said that 1.5 million warrants and 650,000 options were exercised for proceeds of C$150,000 and C$55,500 respectively. "The continued support from key shareholders and insiders as we approach our maiden drill program on our Silver Cloud gold project in Nevada speaks volumes," said Andrew Pollard, the firm's CEO. "These funds will be put to good use, as we follow up on previous high-grade gold intercepts from both Teck and Placer Dome to test our geologic interpretation which suggests a low-sulphidation epithermal gold east-west vein system with two kilometers of strike potential. With drill permits in hand, we expect to move quickly."

CROP Infrastructure Corp (CSE:CROP) (OTCMKTS:CRXPF) said Elite Ventures Group LLC, in which it holds a 49% membership interest, has agreed to extend the proposed closing date of its previously announced commercial real estate purchase agreements with a buyer for a Nevada property owned by Elite to a date on or before September 20, 2019. In addition, CROP unit, The Hempire Company has also agreed to extend the closing date of the agreement  with the buyer, in which Hempire agreed to sell four active, authenticated, usable, uninhibited and transferrable Nevada Marijuana Certificates to a date on or before August 23. These extensions are conditional on the buyer depositing into escrow C$1 million as a deposit.

Flowr Corp (CVE:FLWR) said the TSX Venture Exchange has accepted for filing the documentation relating to the share purchase agreement, dated June 24, 2019, between the company, Pleiades Trading Ltd. and DFT Trading Ltd with respect to its acquisition of the remaining 80.2% interest in Holigen Holdings Ltd. Under the terms of the agreement, the total consideration included $6,299,423.76 in cash consideration and up to a maximum amount of $365,188.73 to the purchase of certain loans, and the company also agreed to pay the aggregate amount of 1,378,106.53 euros to certain of Holigen's creditors. In addition, the company has issued 32,632,545 Series 1 voting convertible redeemable preferred shares of the company, which will convert into common shares of the company on a 1:1 basis.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Seelos Therapeutics named herein, including the promotion by the Company of Seelos Therapeutics in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CytoDyn reveals its drug inhibits colon carcinoma metastases...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive its flagship drug leronlimab inhibited a human colon carcinoma cell line metastases to liver and lung in a well-accepted mouse model. Pourhassan says the company plans to file an IND for expanded access for a Phase 2 basket...

8 hours, 13 minutes ago

9 min read